Kidney Stones Are Associated with Metabolic Syndrome in a Health Screening Population: a Cross-sectional Study

Overview

Journal Transl Androl Urol

Date 2023 Jul 10

PMID 37426600

Authors

Liangli Chen

Junlu Zhang

Keqing Shen

Yue Zhu

Jia Zhang

Jianjiang Pan

Liying Chen

Affiliations

Soon will be listed here.

Abstract

Background: In parallel with the rise in obesity and metabolic syndrome (MetS), kidney stones are becoming more common. In this study, the relationship between MetS components and kidney stones in a health screening population was examined.

Methods: Subjects who underwent health checkups in the Health Promotion Centre of Sir Run Run Shaw Hospital of Zhejiang University between January 2017 and December 2019 were recruited for this study. In this cross-sectional study, 74,326 participants were aged 18 or older. MetS diagnostic criteria were based on the joint statement of the International Diabetes Federation (IDF) and other associations on MetS in 2009. The association between MetS and its components with kidney stones was examined using multivariable logistic regression.

Results: A total of 74,326 participants took part in this cross-sectional study, including 41,703 men (56.1%) and 32,623 women (43.9%). There were 24,815 (33.4%) patients with MetS and 2,032 (2.7%) patients with kidney stones. The prevalence of kidney stones was 3.3% in subjects with MetS and 2.4% in subjects without MetS (P<0.001). The odds ratio and 95% confidence interval (CI) for kidney stones in MetS patients were 1.157 (95% CI: 1.051-1.273). Accordingly, the prevalence of kidney stones showed a statistically significant trend of gradual increase as the number of MetS components increased (P<0.001). Among the components of MetS, elevated waist circumference, reduced high-density lipoprotein cholesterol (HDL-C), and elevated fasting blood glucose (FBG) were independent influencing factors of kidney stones (P<0.001), with odds ratios of 1.205 (95% CI: 1.085-1.337), 1.222 (95% CI: 1.105-1.351) and 1.335 (95% CI: 1.202-1.482), respectively.

Conclusions: MetS is an independent risk factor for kidney stones. Therefore, the control of MetS may help reduce the incidence of kidney stones.

Citing Articles

Dietary index for gut microbiota and its protective role against kidney stones: evidence of diabetes as a mediator from NHANES cross-sectional data.

Wang L, Wu J, Jiang Z, Wang C, Lin F, Zhong Y Front Nutr. 2025; 12:1532313.

PMID: 40008311 PMC: 11852834. DOI: 10.3389/fnut.2025.1532313.

Association between triglyceride glucose index-related indices and kidney stones in adults based on NHANES 2007-2020.

Liu M, Yang P, Gou Y Front Endocrinol (Lausanne). 2025; 15():1516982.

PMID: 39839481 PMC: 11746126. DOI: 10.3389/fendo.2024.1516982.

Characteristics and Yield of Modern Approaches for the Diagnosis of Genetic Causes of Kidney Stone Disease.

Spasiano A, Treccani M, De Tomi E, Malerba G, Gambaro G, Ferraro P Genes (Basel). 2024; 15(11).

PMID: 39596670 PMC: 11593538. DOI: 10.3390/genes15111470.

Kidney Stones of Type I vs. Type II Diabetic Patients: Are There Any Differences?.

Pricop C, Ivanuta M, Nikolic M, Puia D J Clin Med. 2024; 13(20).

PMID: 39458060 PMC: 11508552. DOI: 10.3390/jcm13206110.

[Association between the triglyceride-glucose index and the incidence of nephrolithiasis in male individuals].

Zheng S, Hua T, Yin G, Zhang W, Yao Y, Li Y Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(4):610-616.

PMID: 39041554 PMC: 11284483.

References

Lu J, Wang L, Li M, Xu Y, Jiang Y, Wang W . Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance. J Clin Endocrinol Metab. 2016; 102(2):507-515. DOI: 10.1210/jc.2016-2477. View

Mao W, Zhang H, Xu Z, Geng J, Zhang Z, Wu J . Relationship between urine specific gravity and the prevalence rate of kidney stone. Transl Androl Urol. 2021; 10(1):184-194. PMC: 7844516. DOI: 10.21037/tau-20-929. View

Oh S, Han K, Han S, Koo H, Kim S, Chin H . Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat. Medicine (Baltimore). 2015; 94(39):e1650. PMC: 4616840. DOI: 10.1097/MD.0000000000001650. View

Assadi F, Moghtaderi M . Preventive Kidney Stones: Continue Medical Education. Int J Prev Med. 2017; 8:67. PMC: 5609393. DOI: 10.4103/ijpvm.IJPVM_17_17. View

Semins M, Shore A, Makary M, Magnuson T, Johns R, Matlaga B . The association of increasing body mass index and kidney stone disease. J Urol. 2009; 183(2):571-5. PMC: 3375596. DOI: 10.1016/j.juro.2009.09.085. View

Taylor E, Stampfer M, Curhan G . Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005; 68(3):1230-5. DOI: 10.1111/j.1523-1755.2005.00516.x. View

Kim H, Kim Y, Cho Y, Jun B, Oh K . Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998-2012. Int J Cardiol. 2014; 174(1):64-72. DOI: 10.1016/j.ijcard.2014.03.163. View

Aguilar M, Bhuket T, Torres S, Liu B, Wong R . Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015; 313(19):1973-4. DOI: 10.1001/jama.2015.4260. View

Maalouf N, Sakhaee K, Parks J, Coe F, Adams-Huet B, Pak C . Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004; 65(4):1422-5. DOI: 10.1111/j.1523-1755.2004.00522.x. View

10.

Stamatelou K, Francis M, Jones C, Nyberg L, Curhan G . Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63(5):1817-23. DOI: 10.1046/j.1523-1755.2003.00917.x. View

11.

Rendina D, Mossetti G, DE Filippo G, Benvenuto D, Vivona C, Imbroinise A . Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2008; 24(3):900-6. DOI: 10.1093/ndt/gfn548. View

12.

Cameron M, Maalouf N, Adams-Huet B, Moe O, Sakhaee K . Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006; 17(5):1422-8. DOI: 10.1681/ASN.2005121246. View

13.

Song Q, Zhao Y, Liu Y, Zhang J, Xin S, Dong G . Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab Vasc Dis Res. 2015; 12(3):189-98. DOI: 10.1177/1479164114562410. View

14.

Chobanian M, Hammerman M . Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol. 1987; 253(6 Pt 2):F1171-7. DOI: 10.1152/ajprenal.1987.253.6.F1171. View

15.

Pearle M, Calhoun E, Curhan G . Urologic diseases in America project: urolithiasis. J Urol. 2005; 173(3):848-57. DOI: 10.1097/01.ju.0000152082.14384.d7. View

16.

Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L . Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017; 120(1):109-116. DOI: 10.1111/bju.13828. View

17.

Heller H, Sakhaee K, Moe O, Pak C . Etiological role of estrogen status in renal stone formation. J Urol. 2002; 168(5):1923-7. DOI: 10.1016/S0022-5347(05)64264-4. View

18.

Obligado S, Goldfarb D . The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008; 21(3):257-64. DOI: 10.1038/ajh.2007.62. View

19.

Kahn B, Flier J . Obesity and insulin resistance. J Clin Invest. 2000; 106(4):473-81. PMC: 380258. DOI: 10.1172/JCI10842. View

20.

Sakhaee K . Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2008; 75(6):585-95. PMC: 3088505. DOI: 10.1038/ki.2008.626. View